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Abstract
Previously, we demonstrated that the p190 Rho gua-
nine nucleotide exchange factor (p190RhoGEF) was 
induced following CD40 stimulation of B cells. In this 
study, we examined whether p190RhoGEF and a down-
stream effector molecule RhoA are required for B cell 
differentiation. Expression of p190RhoGEF positively 
correlated with the expression of surface markers and 
transcriptional regulators that are characteristic of ma-
ture  B  cells  with  plasma  cell  (PC)  phenotypes. 
Moreover, either the overexpression of p190RhoGEF 
or the expression of a constitutively active RhoA drove 
cellular differentiation toward PC phenotypes. B cell 
maturation was abrogated in cells that overexpressed 
p190RhoGEF and a dominant-negative form of RhoA 
simultaneously.  CD40-mediated  maturation  events 
were also abrogated in cells that overexpressed either 
dominant-negative p190RhoGEF or RhoA. Together, 
these data provide evidence that p190RhoGEF signal-
ing through RhoA in CD40-activated B cells drives the 
induction of the PC differentiation. 
Keywords: antigens, CD40; ARHGAP35 protein, hu-
man;  B-lymphocytes;  CD40;  cell  differentiation; 
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Introduction
Many of the signaling molecules and transcription 
factors that regulate B cell fate decisions have 
been well characterized. Key transcriptional regu-
lators, including B lymphocyte-induced maturation 
protein-1 (Blimp-1), X-box-binding protein-1 (XBP-1), 
and interferon regulatory factor-4 (IRF-4), are re-
quired for plasma cell (PC) differentiation and func-
tion (Calame, 2001; Shapiro-Shelef and Calame, 
2005). Blimp-1 is a major regulator of PC differ-
entiation and generation of Ab-secreting cells 
(Turner  et al., 1994; Shaffer et al., 2002, 2004; 
Shapiro- Shelef et al., 2003). Blimp-1 suppresses 
the transcriptional repressor paired- box-protein 5 
(Pax5), which is essential for the commitment of 
lymphoid progenitors to the B cell lineage, and also 
functions in late B cell development and activation 
by inducing activation-induced deaminase (AID) 
expression (Delogu et al., 2006; Klein et al., 2006; 
Nera et al., 2006). AID, a novel member of the 
RNA editing cytidine deaminase family, is specifi-
cally expressed in germinal center (GC) B cells 
and is essential for somatic hypermutation and iso-
type switching/class switch recombination (Gray et 
al., 1994; Muramatsu et al., 2000; Xu et al., 2007). 
Blimp-1 suppresses another transcriptional re-
pressor, B cell lymphoma protein-6 (Bcl-6), a major 
regulator of GC B cells (Ye et al., 1997; Delogu et 
al., 2006; Nera et al., 2006). Blimp-1 is thought to 
act upstream of XBP-1, a transcriptional regulator 
of the secretory pathway in PC (Reimold et al., 
2001). Recently, IRF-4 has also been identified as 
a second major gene in PC differentiation (Klein et 
al., 2006; Sciammas et al., 2006).B cell differentiation by p190RhoGEF expression    139
Figure 1. p190RhoGEF protein levels and changes after CD40 stimulation of B cells of various maturational stages. (A) Mouse splenic B cells (1 × 10
6/ml) 
and the B cell lines WEHI 231, BAL17, CH12.LX (5 × 10
5/ml) were stimulated with isotype control Ig or anti-CD40 at a concentration of 1 μg/ml for 48 h. 
(B) HEK 293T cells were transfected with plasmids carrying an empty vector (EV), WT, or DN p190RhoGEF (HA). (C) WEHI 231 B cells were stably trans-
fected with MIGR1 (EV), WT, or DN p190RhoGEF. Lysates were prepared from these cells, subjected to a SDS-PAGE (6% or 8% gels), transferred to ni-
trocellulose, and probed with an Ab specific for p190RhoGEF (A-C) or HA (B). Equal loading of the protein samples was demonstrated by anti-β actin IB 
in (A). (D, E) Mouse splenic B cells (1 × 10
6/ml) were stimulated with control Ig or anti-CD40 at a concentration of 1 μg/ml. After 48 h of stimulation, cells 
were fixed, permeabilized, and stained for endogenous p190RhoGEF, CD23, and IgD. The fluorescence intensities of cells stained with an isotype control 
Ab or antiserum were all corrected (data not shown). The results from flow cytometry are presented as a dot plot, showing IgD versus CD23 positive cells. 
For the cell populations in R1, R2, and R3 as indicated in (D), the population of cells (%) and the expression level of p190RhoGEF as mean fluorescence 
intensity (MFI) in the absence (control) and presence of CD40 stimulation is presented in (E). The results shown are representative of three independent 
experiments.
    CD40 is an important cell surface receptor for 
Ag-dependent and T helper cell-regulated terminal 
differentiation of naïve B cells into Ab-secreting 
plasma and memory cells. The molecular mecha-
nisms underlying the developmental coordination 
of CD40 stimulation with Ig secretion has been well 
characterized by many groups (Gray et al., 1994; 
Kawabe et al., 1994; Benson et al., 2007). However, 
the context in which CD40-CD154 signaling acts to 
activate transcription factors that regulate B cell 
fate decisions is not clearly understood.
    Previously, we identified the p190 Rho guanine 
nucleotide exchange factor (p190RhoGEF) as a 
protein that is strongly induced in response to CD40 
stimulation of B cells (Lee et al., 2003). We also 
demonstrated that the expression of p190RhoGEF 
is correlated with changes in cellular structure fol-
lowing CD40 stimulation in WEHI 231 B cells (Lee 
et al., 2003). Furthermore, cells that transiently 
overexpressed p190RhoGEF behaved as if they 
expressed a constitutively active (CA) form of 
RhoA (Q63L), whereas transient overexpression of 
dominant negative (DN) forms of p190RhoGEF 
(Y1003A) or RhoA (T19N) blocked the CD40-medi-
ated activation effects (Lee et al., 2003). These re-
sults suggest that there may exist a relationship 
between p190RhoGEF, the morphological changes 
in CD40-activated B cells, and additional B cell ma-
turation and differentiation events.
        In the present study, we examined whether 
p190RhoGEF expression is correlated with the ex-
pression of specific surface markers and transcrip-
tional regulators that are characteristic of both ma-
ture and differentiated B cells. We also examined 
whether the activities of p190RhoGEF and RhoA 
are required for CD40-mediated B cell maturation 
and differentiation. Our results demonstrate that 
the expression of p190RhoGEF correlates with the 
expression of the cell surface markers CD138 
(syndecan-1) and CXCR4, as well as the tran-
scription factors Blimp-1, XBP-1, and IRF-4. The 
expression of these molecules was also induced 
following CD40 stimulation, as well as by over-
expressing either wild type (WT) p190RhoGEF or a 140    Exp. Mol. Med. Vol. 44(2), 138-148, 2012
Figure 2. Expression of p190RhoGEF, CD138, and B220 in B cells at various maturational stages. (A, B) Mouse splenic B cells (1 × 10
6/ml) were stimu-
lated with control Ig or anti-CD40 at a concentration of 1 μg/ml. After 72 h of stimulation, cells were fixed, permeabilized, and stained for endogenous 
p190RhoGEF, B220, and CD138. The fluorescence intensities of cells stained with an isotype control Ab or antiserum were all corrected (data not shown). 
The results from flow cytometry are presented as a dot plot, showing the B220 positive cells versus the CD138 positive cells. The data shown are repre-
sentative of three independent experiments. For the cell populations indicated in (A), expression of p190RhoGEF is presented as MFI in (B). Data are pre-
sented as the mean (n =4 )± SD. (C, D) The B cell lines, BAL17, CH12.LX, and NS-1 were fixed, permeabilized, and stained for endogenous 
p190RhoGEF, CD138, and B220. The results were obtained as described above. For the cell populations indicated in (C), expression of p190RhoGEF is 
presented as MFI in (D). Data are presented as the mean (n =3 )± SD.
CA form of RhoA (Q63L). Collectively, these data 
suggest a specific contribution of p190RhoGEF to 
CD40-mediated differentiation and that p190RhoGEF 
may be a crucial component of T cell-dependent B 
cell maturation and differentiation.
Results
Changes in expression of surface markers and 
p190RhoGEF by CD40 stimulation
We previously reported that a 48 h stimulation of 
CD40 leads to increases in p190RhoGEF expression 
and causes characteristic structural changes in B 
cells (Lee et al., 2003). Because the cellular struc-
ture of B cells changes during cell maturation, we 
tested whether p190RhoGEF expression corre-
lates with stages in the maturation of B cells follow-
ing CD40 stimulation. Analysis of the protein levels 
of p190RhoGEF in B cells of various maturational 
stages also demonstrated that there was an in-
crease in p190RhoGEF protein levels following 
CD40 stimulation of WEHI 231 and splenic B cells, 
but not the mature B cell lines, BAL17 and 
CH12.LX (Figure 1A). The specificity of the poly-
clonal Ab generated against p190RhoGEF was 
characterized in HEK 293T cells transfected with 
hemagglutinin (HA)-p190RhoGEF expression plas-
mids (Figure 1B) and in WEHI 231 B cells in which 
p190RhoGEF was overexpressed (Figure 1C).
    As B cell maturation progresses, expression of 
CD23 is increased and expression of IgD is 
decreased. We further analyzed expression of the 
surface markers IgD and CD23. We used flow cy-B cell differentiation by p190RhoGEF expression    141
Figure 3. Expression changes of transcriptional regulators after CD40 
stimulation and in response to p190RhoGEF and RhoA down-regulation 
in B cells at various maturational stages. (A) cDNA was prepared from B 
cells that were either untreated (control) or stimulated for 24 h with an-
ti-CD40 (1 μg/mL). (B) cDNA was prepared from BAL17 and NS-1 cells 
that were stably transfected with MIGR1 (EV), p190RhoGEF (Y1003A) or 
RhoA (T19N). The PCR products for p190RhoGEF, RhoA, Blimp-1, 
XBP-1, IRF-4, and GAPDH were separated as described in “Methods.”
The data shown are representative of three independent experiments. 
Values indicate normalization for GAPDH.
tometry to analyze whether CD40 stimulation 
caused changes in the expression of IgD and 
CD23. Changes in the expression level of IgD ver-
sus CD23 in mouse splenic B cells treated with an-
ti-CD40 are shown in Figure 1D. B cell population 
was defined as three groups (R1: CD23
low, R2: 
CD23
medium, R3: CD23
low) based on the level of 
CD23 expression. Results in Figure 1D and 1E 
demonstrate that CD40 stimulation of these B cells 
results in a change in maturation stage, indicated 
as a percentage of cell population in R1-R3. 
p190RhoGEF expression correlates to changes in 
cellular maturation both in unstimulated control and 
CD40 stimulation of splenic B cells (Figure 1E).
Expression of p190RhoGEF is correlated with the 
expression of CD138 and transcriptional regulators 
driving PC differentiation
To determine whether p190RhoGEF expression in-
duced by CD40-stimulated B cell activation is in-
volved in PC differentiation, we correlated the ex-
pression of p190RhoGEF with the expression of a 
specific surface molecule, CD138, which has been 
previously implicated as a PC marker (Calame, 
2001; Shapiro-Shelef and Calame, 2005). B cell 
population was separated by the expression level 
of B220 and CD138 (R1: B220
highCD138
low, R2: 
B220
highCD138
high, R3: B220
lowCD138
high). By flow 
cytometry, we found that following 72 h of CD40 
stimulation, the B cell population expressing CD138 
on the surface increased from -7.4% to -20% (R2 
and R3) in mouse splenic B cells (Figure 2A). 
Accordingly, the expression of p190RhoGEF was 
analyzed in the regions (R1, R2, and R3) sepa-
rated by the expression level of B220 and CD138. 
As shown in Figure 2B, p190RhoGEF expression 
increased in R2 and R3 in mouse splenic B cells 
over the expression level in R1 both in unstimulated 
controls and following CD40 stimulation. CD40 
stimulation also increased p190RhoGEF expression 
-2-fold in R1compared to the level of unstimulated 
controls.
    To  directly  correlate  the  expression  of 
p190RhoGEF with PC differentiation, we analyzed 
the expression levels of B220 versus CD138 in the 
mature B cell lines with PC phenotypes, BAL17 
and CH12.LX, and in plasmacytoma NS-1 cells. As 
shown in Figure 2C, populations demonstrating 
distinct maturation stages differ slightly when 
R1-R3 are compared. Further analysis of the ex-
pression of p190RhoGEF in these cell populations 
demonstrated that p190RhoGEF expression is 
much higher in cells that show more characteristics 
of PC with higher population in R3 (CH12.LX and 
NS-1 cells with higher population in R3 vs. BAL17 
cells with lower population in R3 (Figure 2D).
    Because the transcriptional regulators, Blimp-1, 
XBP-1, and IRF-4 are known to play key roles in 
PC development (Turner et al., 1994; Reimold et 
al., 2001; Shaffer et al., 2002; Shapiro-Shelef et al., 
2003; Shaffer et al., 2004; Klein et al., 2006; 
Sciammas et al., 2006), we next examined whether 
p190RhoGEF expression also correlated with the 
expression of these transcriptional regulators. The 
expression of Blimp-1, XBP-1, and IRF-4 was com-
pared with the CD40-induced changes in these 
regulators compared to the unstimulated controls. 
As shown in Figure 3A, CD40 stimulation greatly 
enhanced the expression of these transcripts in 
WEHI 231 and splenic B cells. In contrast, the ex-
pression of Blimp-1, XBP-1, and IRF-4 is high in 
BAL17 and CH12.LX cells, independent of CD40 
stimulation (Figure 3A).
    Similarly,  p190RhoGEF  expression  was  con-
stitutively high in BAL17 and CH12.LX cells, but 
was induced in WEHI 231 and splenic B cells after 142    Exp. Mol. Med. Vol. 44(2), 138-148, 2012
Figure 4. Direct effects of manipulating the activity of p190RhoGEF and RhoA on B cell maturation and downstream transcriptional regulators. WEHI 231 
B cells were stably transfected with MIGR1 (EV), WT p190RhoGEF, DN p190RhoGEF (Y1003A), CA RhoA (Q63L), DN RhoA (T19N), or a combination of 
WT p190RhoGEF and DN RhoA (T19N). (A) cDNA was prepared from these stably transfected cells. The PCR products for p190RhoGEF, RhoA, Blimp-1, 
XBP-1, IRF-4, Bcl-6, AID, and GAPDH were separated as described in “Methods.” The data shown are representative of three independent experiments. 
Values indicate normalization for GAPDH. (B) These stably transfected cells were removed from the cultures and then washed, counted, and recultured in 
fresh medium for 24 h at 1 × 10
6 cells/ml. Some EV-transfected cells were also incubated with a medium alone (black bars) or with a combination of 
CD40 and IL4 as positive controls (white bars). Supernatants were harvested and serially diluted, and secreted Ig was measured by anti-IgM and anti-IgG 
ELISA as described in “Methods.” Values of the optical densities at 490 nm in triplicate supernatant samples were collected in each independent 
experiment. Data are presented as the mean of three independent experiments (n = 3) ± SD, *P ＜ 0.05, **P ＜ 0.01, compared with cells transfected 
with EV. (C, D) These stably transfected cells were fixed, stained with anti-CD138 or anti-CXCR4, and analyzed by standard flow cytometry. The fluo-
rescence intensities of cells stained with an isotype control Ab or antiserum were all corrected (data not shown).The bar graphs show the expression of 
CD138 (C) or CXCR4 (D), as indicated by MFI. Data are presented as the mean of three independent experiments (n =3 )± SEM, **P ＜ 0.01, ***P ＜
0.001, compared with cells transfected with EV.
CD40 stimulation (Figures 1A and 3A). These re-
sults strongly suggest that the expression of 
p190RhoGEF mediates the induction of key tran-
scriptional regulators, Blimp-1, XBP-1, and IRF-4, 
which regulate B cell maturation and differentiation.
    Because  p190RhoGEF  specifically  activates 
RhoA (Gebbink et al., 1997; van Horck et al., 
2001), we next examined whether the activities of 
p190RhoGEF and its downstream effector RhoA 
are required during PC differentiation. As shown in 
Figure 3B, the expression levels of the major 
transcriptional regulators of PC maturation and 
differentiation, Blimp-1 and XBP-1 were greatly 
reduced in BAL17 cells transfected with a DN form 
of p190RhoGEF (Y1003A) or RhoA (T19N). These 
results strongly suggest that one function of 
p190RhoGEF is to maintain the expression of key 
transcriptional regulators of B cell maturation and 
differentiation. In contrast, the DN form of either 
p190RhoGEF or RhoA had no effect on the 
expression of these transcription factors in NS-1 
cells (Figure 3B). These results also suggest that 
p190RhoGEF functions in maturing B cells, but not 
in completely differentiated plasmacytoma cells.B cell differentiation by p190RhoGEF expression    143
Figure 5. Effects of the overexpressed DN forms of p190RhoGEF or 
RhoA on the expression of CD138, CXCR4, and transcriptional regu-
lators after CD40 stimulation. WEHI 231 B cells were stably transfected 
with either MIGR1 (EV), a plasmid encoding DN p190RhoGEF (Y1003A), 
or a plasmid encoding DN RhoA (T19N). (A, B) After CD40 stimulation 
for 48 h, cells were fixed, stained with anti-CD138 or anti-CXCR4, and 
measured by flow cytometry. The fluorescence intensities of cells stained 
with an isotype control Ab or antiserum were all corrected (data not 
shown). The results show the expression intensities of CD138 (A) or 
CXCR4 (B). Data are presented as the mean of three independent ex-
periments (n =3 )± SD. (C) cDNA was prepared from these stably 
transfected cells, after being stimulated for 48 h with anti-CD40 Ab (1 
μg/ml). The PCR products for p190RhoGEF, RhoA, Blimp-1, XBP-1, 
IRF-4, and GAPDH were separated as described in “Methods.” The data 
shown are representative of three independent experiments. Values in-
dicate normalization for GAPDH.
Expression of p190RhoGEF and activation of RhoA 
mimic CD40-induced B cell maturation and 
differentiation
We next determined whether p190RhoGEF ex-
pression induced by CD40-stimulated B cell activa-
tion is involved in the PC differentiation process. To 
determine the requirement for p190RhoGEF in ex-
pression of the key transcriptional regulators Blimp-1, 
XBP-1, and IRF-4, we transfected WEHI 231 B 
cells with a plasmid encoding a WT or DN form of 
p190RhoGEF and measured the subsequent ex-
pression of these regulators. We found that the ex-
pression of these transcription factors increased in 
cells transfected with WT p190RhoGEF, as well as 
a CA RhoA (Q63L), compared to cells transfected 
with the DN form of the proteins (Figure 4A). The 
expression of Blimp-1, XBP-1, and IRF-4 was not 
induced in cells that simultaneously expressed the 
WT p190RhoGEF and DN RhoA (T19N) (Figure 
4A). Induced expression of Blimp-1 in WEHI 231 B 
cells transfected with WT p190RhoGEF or CA 
RhoA (Q63L) stimulated these cells to become 
Ab-secreting cells by suppressing Bcl-6 and AID 
expression (Figure 4A). Secretion of IgM and IgG 
Ab was detected high in the supernatants of these 
cells transfected with the WT p190RhoGEF as well 
as CA RhoA (Q63L) (Figure 4B). Some transcrip-
tional increase shown in cells transfected with DN 
forms of p190RhoGEF and RhoA could possibly 
be due to controlled regulation by overexpression 
of these plasmids. 
    Similarly, we found that expression of the B cell 
surface differentiation markers CD138 and CXCR4 
increased significantly in cells transfected with WT 
p190RhoGEF, but expression was unchanged in 
cells transfected with the DN plasmid (Figures 4C 
and 4D). We also found that these surface markers 
were upregulated in cells transfected with CA 
RhoA (Q63L) but not much in cells transfected with 
the DN form of RhoA (T19N) (Figures 4C and 4D). 
Moreover, the expression of surface markers in 
cells that simultaneously expressed DN RhoA 
(T19N) and WT p190RhoGEF was not induced, 
confirming that RhoA acts downstream of 
p190RhoGEF (Figures 4C and 4D).
The p190RhoGEF-RhoA activation is required for the 
CD40-induced B cell differentiation
We also tested to see whether p190RhoGEF-RhoA 
activation is required for CD40-induced expression 
of surface molecules. In cells that were transfected 
with a vector plasmid, CD40 stimulation induced 
the expression of cell surface molecules (Figures 
5A and 5B). However, in cells that were transfected 
with a DN form of either p190RhoGEF (Y1003A) or 
RhoA (T19N), CD40 stimulation had no effect on 
cell surface protein levels (Figures 5A and 5B).
    Additionally, CD40 stimulation had no effect on 
the expression of transcriptional regulators in cells 
that were transfected with a DN form of either 
p190RhoGEF (Y1003A) or RhoA (T19N). However, 
in RhoA (T19N)-transfected WEHI 231 cells, 
p190RhoGEF induction was shown (Figure 5C). In 
cells that were transfected with a vector plasmid, 
CD40 stimulation induced the expression of 
p190RhoGEF, but had little effect on RhoA ex-
pression levels (Figure 5C). These results strongly 
suggest that the enhanced activation of RhoA is 144    Exp. Mol. Med. Vol. 44(2), 138-148, 2012
mediated by p190RhoGEF after CD40 stimulation 
in WEHI 231 B cells.
Discussion
CD40 is an important surface receptor that is in-
volved in the activation and maturation of B cells 
during immune responses (Foy et al., 1994; Gray 
et al., 1994; Kawabe et al., 1994; Xu et al., 1994; 
Arpin et al., 1995; Randall et al., 1998; Yoon et al., 
2005). CD40-CD154 interactions are crucial for the 
initiation and propagation of GC reactions following 
exposure to exogenous Ag and for the production 
of high affinity, class-switched Ab. However, the 
role of CD40 signaling in B cell differentiation is 
controversial (Foy et al., 1994; Gray et al., 1994; 
Kawabe et al., 1994; Xu et al., 1994; Arpin et al., 
1995; Randall et al., 1998). Earlier studies have in-
dicated that the stimulation of B cells through 
CD40 leads to the development of memory B cells 
and not PCs (Arpin et al., 1995). Studies have also 
demonstrated that the interaction of CD40 with its 
cell surface ligand CD154 actively suppresses Ig 
secretion in B cells and eventually allows for the 
selection of high affinity Ig-producing cells in the 
GC (Randall et al., 1998). In contrast, other reports 
have suggested that signaling through CD40 pro-
motes the terminal differentiation of B cells into 
PCs and Ig secretion, particularly in combination 
with cytokines (Foy et al., 1994; Gray et al., 1994; 
Xu et al., 1994). Several studies have also demon-
strated CD40-dependent, T cell-dependent, humor-
al immunity through the disruption of genes in-
volved in CD40 signaling pathways (Ahonen et al., 
2002; Jabara et al., 2002; Gallagher et al., 2007). 
Here, we have shown that CD40 signaling through 
p190RhoGEF induces expression of the tran-
scription factors Blimp-1, XBP-1, and IRF-4, as well 
as the cell surface proteins CD138 and CXCR-4, 
which drive cells to become Ab-secreting cells.
    p190RhoGEF, which was cloned and identified 
as a RhoA specific GEF (Gebbink et al., 1997; van 
Horck et al., 2001), has not been reported to func-
tion in immune cells. We previously reported that 
expression of p190RhoGEF is markedly enhanced 
after CD40 stimulation in WEHI 231 B cells and is 
correlated with cellular structural changes and 
NF-κB activation (Lee et al., 2003). These results 
may indicate that this protein plays a significant 
role in CD40-mediated B cell activation and 
maturation. Here, we investigated the specific con-
tribution of p190RhoGEF in CD40-stimulated cells 
in order to further our understanding of the molec-
ular mechanisms underlying B cell maturation and 
differentiation.
    Ag-dependent terminal differentiation of naïve B 
cells requires T helper cell regulation for cell ex-
pansion and effector and memory cell development. 
Recently, naïve B cell priming, which is central to 
the initiation phase of T cell-dependent B cell re-
sponses, has been studied extensively (Gray, 
2002; McHeyzer-Williams and McHeyzer-Williams, 
2005). The transcription factor Blimp-1 has been 
shown to be both necessary and sufficient for the 
differentiation of naïve B cells into PCs (Turner et al., 
1994; Shaffer et al., 2002, 2004; Shapiro-Shelef et 
al., 2003). Deletion of the transcription factor Pax5, 
which is continuously required to maintain B cell 
identity by alternate lineage genes, results in the 
down-regulation of the GC transcriptional regulator 
Bcl-6, which consequently induces expression of 
the PC transcription factors Blimp-1 and XBP-1 (Ye 
et al., 1997; Reimold et al., 2001; Delogu et al., 
2006; Nera et al., 2006). In an activated GC B cell 
state, physiological levels of Blimp-1 expression 
are induced by the down-regulation of Pax5 as well 
as by positive regulatory inputs from the Ag and 
cytokine receptor signaling systems (Delogu et al., 
2006; Nera et al., 2006). Although recent studies 
have begun to dissect cellular events within the 
GC (Kallies et al., 2007), there are still many un-
answered questions as to how PCs become termi-
nally differentiated.
    Our findings suggest that the strong stimulation 
of B cells by activated T cells (through CD40-CD154 
interactions), induces Blimp-1 expression and dif-
ferentiation into B cells with PC phenotype. The ex-
pression levels of p190RhoGEF are low in splenic 
B cells as well as in an immature B cell line, WEHI 
231, but increase following CD40 activation (Figures 
1A and 4A). In contrast, elevated p190RhoGEF ex-
pression levels do not increase further following 
CD40 activation in mature B cells that have a PC 
phenotype (e.g., BAL17 and CH12.LX) (Figures 1A 
and 4A). CD40 activation induces a change in B 
cell maturation as well as in p190RhoGEF ex-
pression levels (Figure 1D). The expression levels 
of p190RhoGEF increase in mature B cells with 
PC phenotypes (Figure 2). The expression of key 
transcription factors required for PC differentiation 
(Blimp-1, XBP-1, and IRF-4) was also upregulated 
by CD40 activation (Figure 3A). Overexpression of 
the DN form of p190RhoGEF or RhoA in mature 
BAL-17 B lymphoma cells significantly diminished 
the level of these transcriptional regulators (Figure 
3B). Interestingly, these negative regulatory effects 
on B cell maturation were not seen in experiments 
where p190RhoGEF activity was blocked in plas-
macytoma cells, which are terminally differentiated 
(Figure 3B). Moreover, overexpression of the WT 
or DN forms of p190RhoGEF or RhoA directly B cell differentiation by p190RhoGEF expression    145
modulated the expression of these transcription 
factors in the absence of CD40 stimulation in 
WEHI 231 B cells (Figure 4A). Secretion of IgM 
and IgG Ab in the supernatants of cells transfected 
with the WT p190RhoGEF as well as CA RhoA 
(Q63L) (Figure 4B) suggest that p190RhoGEF also 
regulates AID expression in the GC reaction before 
turning on the expression of Blimp-1, which in-
duces PC differentiation. Our results indicate that 
p190RhoGEF is induced in activated B cells by 
CD40 and is required for initial triggering of GC B 
cell differentiation into cells of PC phenotype. 
    The Rho family of GTPases has been shown to 
regulate cell polarization, motility, and chemotaxis 
in many cell types (Ridley, 2001; Boettner and 
Aelst, 2002; Etienne-Manneville and Hall, 2002; 
Meili and Firtel, 2003). Specifically, RhoA regulates 
the maturation of focal complexes into focal adhe-
sions and the formation of associated stress fibers 
(Rottner et al., 1999; Ridley, 2001; Burridge and 
Wennerberg, 2004). Our previous study demon-
strated that the structural changes following CD40 
stimulation of B cells was due to p190RhoGEF-in-
duced RhoA activity (Lee et al., 2003). Those re-
sults are consistent with the findings from this in-
vestigation which show that changes in cellular 
morphology are regulated by p190RhoGEF during 
CD40-mediated B cell activation and are correlated 
with Blimp-1 expression and B cell differentiation. 
Recent studies in macrophages have also shown 
that Bcl-6 alters macrophage morphology and mo-
tility by suppressing RhoA activity (Pixley et al., 
2005). In this respect, a number of recent studies 
have highlighted the importance of the cytoskele-
ton in various lymphocytic functions including mi-
gration, Ag recognition, signaling, and activation 
(Vicente-Manzanares and Sanchez-Madrid, 2004). 
Thus, additional studies are needed to determine 
whether cytoskeletal reorganization during CD40- 
mediated B cell activation contributes to GC B cell 
differentiation into cells of PC phenotype.
    Recent  studies  have  provided  evidence  that 
RhoA is involved in cell signaling and directly con-
trols gene transcription and cell cycle progression 
(Li et al., 2000; Gu et al., 2003, 2005; Walmsley et 
al., 2003). Genetic studies have shown that Rho 
family members are required for normal develop-
ment and functioning of lymphocytes (Li et al., 
2000; Gu et al., 2003, 2005; Walmsley et al., 
2003). RhoA has also been implicated in regulating 
B cell receptor-dependent calcium flux and pro-
liferation (Saci and Carpenter, 2005), as well as 
Wnt-mediated migration and invasion of myeloma 
PCs (Qiang et al., 2005). Here, we provide evi-
dence that RhoA activation is required for B cell 
maturation by CD40 receptor signaling. However, the 
mechanism by which CD40-mediated p190RhoGEF- 
RhoA activation drives the induction of transcrip-
tional regulators, including Blimp-1 and XBP-1, re-
mains to be determined.
    In summary, this report shows that CD40 signal-
ing induces p190RhoGEF expression, which in 
turn activates RhoA and results in the expression 
of surface molecules and transcriptional regulators 
that are required for the maturation and differ-
entiation of B cells. We have demonstrated a 
strong correlation between the expression levels of 
p190RhoGEF, the cell surface markers syndecan-1 
and CXCR4, and the transcriptional regulators 
Blimp-1 and XBP-1. These data implicate RhoA 
and p190RhoGEF as crucial components media-
ting T cell-dependent B cell maturation and differ-
entiation.
Methods
Ab and reagents
The rat anti-mouse CD40 mAb (clone 1C10) from R&D 
Systems, Inc. (Minneapolis, MN) and the hamster an-
ti-mouse CD40 mAb (HM40-3) from BD PharMingen (San 
Diego, CA) were used to stimulate B cells. To isolate splen-
ic B cells, the B cell isolation kit (Miltenyi Biotec, Bergisch 
Giadbach, Germany) was used for depletion of non-B cells 
(negative selection). For cell surface staining, r-phycoery-
thrin (PE)-conjugated rat anti-mouse CD138 (syndecan-1; 
281-2), CXCR4 (2B11), CD23 (B3B4), and peridinin chlor-
ophyll protein (PerCP)-conjugated rat anti-mouse CD45R/ 
B220 (RA-6B2) mAb were purchased from BD Phar-
Mingen. Biotin-conjugated rat anti-mouse IgD (11-26) was 
from Southern Biotechnology Associates (Birmingham, 
AL). FITC-conjugated goat anti-rabbit IgG, allophycocya-
nin- or PerCP-conjugated streptavidin, and isotype control 
Ig’s were purchased from Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA) or BD PharMingen. To 
stain and immunoblot (IB) p190RhoGEF, we generated a 
rabbit polyclonal LF-r-gef Ab using purified GST-p190 
RhoGEF (aa 1424-1615) as the immunogen (Lab Frontier, 
Seoul, Korea) (Meyer et al., 1999). An anti-HA mouse mAb 
(Sigma-Aldrich, St. Louis, MO) and an anti-β-actin (Santa 
Cruz Biotechnology, Inc., Santa Cruz, CA) were used for IB 
analysis. A HRP-conjugated anti-rabbit or anti-mouse IgG 
(Bio-Rad, Hercules, CA) was used as a secondary Ab for 
IB.
Plasmids
The expression plasmids for WT and DN (Y1003A) 
p190RhoGEF (pCDNA3-HA) have been described pre-
viously (van Horck et al., 2001; Lee et al., 2003). To gen-
erate expression plasmids for WT and DN p190RhoGEF 
(MIGR1), the cDNAs encoding WT and DN p190RhoGEF 
were released from the pcDNA3 expression vector by di-
gestion with BglII and NotI and ligated into the pLNCX2 ret-
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before being sub-cloned into the MSCV MIGR1 bicistronic 
vector (a kind gift from W. Pear through G. Koretzky, 
University of Pennsylvania) (Pear et al., 1998), between 
the BglII and SalI/XhoI sites. Plasmids expressing FLAG- 
tagged CA (Q63L) and DN (T19N) RhoA (MIGR1) were 
generated by PCR amplification with FLAG sequence-con-
taining primers from CA and DN RhoA (pRK5-myc) ex-
pression plasmids (kind gifts from Dr. G. M. Bokoch, The 
Scripps Research Institute, La Jolla, CA), followed by liga-
tion into the MSCV MIGR1 bicistronic vector between the 
BglII and EcoRI sites. Each construct was verified by 
sequencing.
Cell culture, treatment, and isolation of splenic B cells
The mouse B lymphoma cell lines, WEHI 231, BAL17, and 
CH12.LX were cultured in B cell medium (RPMI 1640 me-
dium supplemented with 10% heat-inactivated fetal bovine 
serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 20 mM 
glutamine, and 5 × 10
-5 M 2-ME). A plasmacytoma cell 
line, NS-1, was cultured in B cell medium lacking 2-ME. 
The human embryonic kidney cell line HEK 293T was cul-
tured in DMEM supplemented with 10% heat-inactivated 
fetal bovine serum, 100 U/ml penicillin, 100 μg/ml strepto-
mycin, and 20 mM glutamine. The cell lines were main-
tained at 37
oC in 5% CO2/95% O2. Splenic B cells were 
isolated from adult female BALB/c mice (6 to 8 weeks old) 
using the B cell isolation kit (Miltenyi Biotec) for depletion 
of non-B cells (negative selection), according to the manu-
facturer’s instructions. When stimulated, the cells (B lym-
phoma, plasmacytoma, 5 × 10
5/ml; splenic B cells, 1 ×
10
6/ml) were incubated with anti-CD40 at 1 μg/ml for 48 or 
72 h. The handling of animals followed institutional 
guidelines.
Retroviral infection
Phoenix-Ampho cells were transfected with a MIGR1 con-
struct using the calcium phosphate precipitation method 
and viral supernatants were collected as described pre-
viously (Pear et al., 1993). WEHI 231, BAL17, and NS-1 
cells were spin-infected with retroviral supernatants before 
being cultured in growth medium for 4-5 days. Fluorescent 
cells were separated using a FACSAria cell sorter system 
(BD Biosciences).
Transient expression of plasmid DNA
HEK 293T cells were seeded the day before transfection at 
-6 × 10
6 cells/60-mm culture dish. The cells were then 
transfected with 5 μg of various expression plasmids by 
calcium phosphate precipitation. The transfected cells 
were cultured in growth medium for 24 h before ex-
perimental manipulations.
RNA isolation and RT-PCR
Total RNA from B lymphoma cells and splenic B cells that 
were either unstimulated or stimulated was isolated using 
the TRIzol reagent that was purchased from Life 
Technologies (Grand Island, NY). For RT-PCR, the total 
RNA was a template for cDNA synthesis with oligo (dT) as 
the primer. The Oligo (dT)12-18 primer and M-MLV-reverse 
transcriptase were received from Promega (Madison, WI). 
A pair of primers was used to amplify each desired cDNA 
(p190RhoGEF: 5'-gcctctagatcttctctgtggatcgac-3', 5'-tccagc 
agccatctaagcagg-3'; RhoA: 5'-gaagatctatggctgccatcag-3', 
5'-cggaattctcacaagatgaggc-3'; Blimp-1: 5'-gccaaccaggaact 
tcttgtgt-3', 5'-aggataaaccacccgagggt-3'; XBP-1: 5'-gctgcgg 
aggaaactgaaa-3', 5'-gggaggctggtaaggaact-3'; IRF-4: 5'-gaa 
gatctatggctgccatcag-3', 5'-cggaattctcacaagatgaggc-3'; Bcl6: 
5'-tcagagtattcggattctagctgtga-3', 5'-tgcagcgtgtgcctcttg-3'; Pax5: 
5'-gcgtgtttgagagacagcact-3', 5'-aagaatactgagggtggctgt-3'; 
AID: 5'-ggctgaggttagggttccatctcag-3', 5'-gagggagtcaagaaa 
gtcacgctgga-3'; GAPDH: 5'-atcaccatcttccaggagcga-3', 5'-at 
gaccttgcccacagcctt-3'). PCR primers used for Cμ germline 
(245 bp: 5'-tgggcaagtggatctgaaca-3', 5'-gaagacatttgggaagg 
actgact-3'), Cγ1 germline (429 bp: 5'-ggcccttccagatctttgag- 
3', 5'-ggatccagagttccaggtcact-3') and Cγ1 postswitch (353 bp: 
5'-tgggcaagtggatctgaaca-3', 5'-ggatccagagttccaggtcact-3') 
transcripts were as described previously (Muramatsu et al., 
2000). The PCR products were separated on agarose gels. 
The intensity of the bands was quantitated, and the 
normalized values were calculated based on the intensity 
of GAPDH bands.
IB analysis
After stimulation with anti-CD40 or transfection with ex-
pression plasmids, cell lysates were prepared in a 1% 
NP-40 lysis buffer containing protease and phosphatase in-
hibitors, as previously described (Lee and Koretzky, 1998). 
The lysates from B lymphoma cells (5 × 10
5) and splenic B 
cells (1 × 10
6) were mixed with 2 ×Laemmli sample buf-
fer, boiled, and subjected to SDS-PAGE on 6% or 10% 
gels. After transferring proteins to a nitrocellulose mem-
brane, IB was performed by blocking the membrane with 
5% nonfat dried milk and incubating it with Ab against spe-
cific proteins, followed by incubation with an HRP-con-
jugated secondary Ab. Chemiluminescence detection was 
conducted using enhanced chemiluminescence (ECL) re-
agents (Amersham Pharmacia Biotech Co., Arlington Heights, 
IL).
Flow cytometry
B lymphoma cells (5 × 10
5) and splenic B cells (1 × 10
6) 
were blocked with normal rabbit serum (1:1,000) in PBS 
followed by direct 2- or 3-color surface staining with vari-
ous Ab combinations for 30 min on ice in staining buffer 
containing 1% BSA in PBS. These cells, stained directly for 
surface molecules, were then fixed and permeabilized with 
a Cytofix/Cytoperm solution (BD PharMingen) for 20 min at 
4
oC and washed with a Perm/Wash solution (BD 
PharMingen). An Ab specific for p190RhoGEF was added, 
followed by incubation with an FITC- or allophycocya-
nin-conjugated secondary Ab. Control staining was per-
formed by incubating cells with FITC-, r-PE-, PerCP-, and 
allophycocyanin-conjugated anti-mouse IgGs. Stained cells 
were washed and resuspended in PBS. Data were immedi-
ately collected using a FACSCalibur and analyzed using 
CellQuest software (BD Biosciences, Mountain View, CA). 
For each experimental condition, 10,000 cells were analyzed. B cell differentiation by p190RhoGEF expression    147
Fluorescence signals were analyzed as dot plots of the flu-
orescence intensity. The mean fluorescence intensities 
(MFIs) in the gated area, R, are also represented graphi-
cally in the figures.
ELISA for Ig secretion
Culture supernatants collected from fluorescent sorted sta-
ble cells (2 × 10
6/ml) were serially diluted and added to 
96-well Immulon-1 flat-bottomed plates that had been coat-
ed with anti-mouse IgM or IgG in carbonate-bicarbonate 
buffer (15 mM Na2CO3, 35 mM NaHCO3; pH 9.6) for 30 
min at room temperature. The plates were treated with 3% 
bovine serum albumin blocking solution in PBS containing 
0.05% Tween 20 (T-PBS). IgM or IgG was allowed to bind 
for 45 min at room temperature. Next, the plates were 
washed with T-PBS, and biotin-conjugated mouse IgM in 
conjunction with HRP-streptavidin or HRP-labeled mouse 
IgG-specific Ab was added to the wells for 30 min at room 
temperature. After the addition of the peroxidase substrate, 
ο-phenylenediamine dihydrochloride, different Ab isotypes 
were quantified by measuring absorbance at 490 nm with a 
microplate reader (Molecular Devices, Spectra MAX 190).
Other methods
Protein concentrations were determined using the Bradford 
protein assay reagent (Bio-Rad) following the manu-
facturer’s instructions. Comparisons between samples 
were performed using a two-tailed Student’s t test. Statistics 
were determined using Prism software (GraphPad Software, 
Inc.). Values of P ＜ 0.05 were considered significant.
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